First Eagle Investment Management’s Gilead Sciences GILD Stock Holding History

First Eagle Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-300	Closed	-$1K	–	219
2017 Q4	$1K	Hold	300	–	–	﹤0.01%	328
2017 Q3	$43K	Hold	300	–	–	﹤0.01%	314
2017 Q2	$24K	Hold	300	–	–	﹤0.01%	303
2017 Q1	$23K	Hold	300	–	–	﹤0.01%	297
2016 Q4	$75K	Hold	300	–	–	﹤0.01%	276
2016 Q3	$164K	Buy	+300	New	+$24.4K	﹤0.01%	282
2015 Q1	–	Sell	-1,200	Closed	-$685K	–	340
2014 Q4	$685K	Buy	+1,200	New	+$124K	﹤0.01%	245

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Eagle Investment Management's GILD Position: Q1 2018 in Review

First Eagle Investment Management sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 59,700 shares — an estimated $4.28M sold.

First Eagle Investment Management first reported a position in GILD in Q2 2013 and held it in 19 quarters. The position peaked at $124M in Q4 2014. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

First Eagle Investment Management reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
First Eagle Investment Management sold 59,700 Gilead Sciences shares in Q1 2018, an estimated $4.28M.
First Eagle Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 19 quarters.
First Eagle Investment Management's Gilead Sciences position peaked at $124M in Q4 2014.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on First Eagle Investment Management's 13F filing for Q1 2018, filed 4 May 2018.